News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Medivir AB, Interim Report, 1 January – 31 March 2009
April 23, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir (STO:MVIRB):
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Gossamer, BiomX Reveal Hefty Staff Cuts
March 20, 2026
·
39 min read
·
BioSpace Editorial Staff
Policy
Biopharma Could Provide a Haven for Investment as Middle East Conflict Roils Global Markets
March 20, 2026
·
2 min read
·
Annalee Armstrong
Manufacturing
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
March 19, 2026
·
2 min read
·
Nick Paul Taylor
Layoffs
Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail
March 19, 2026
·
2 min read
·
Tristan Manalac
